A common mutation, Arg457→Gln, links prothrombin deficiencies in the Puerto Rican population

被引:27
作者
Lefkowitz, JB
Weller, A
Nuss, R
Santiago-Borrero, PJ
Brown, DL
Ortiz, IR
机构
[1] Univ Colorado, Sch Med, Dept Pathol, Denver, CO 80262 USA
[2] Univ Colorado, Sch Med, Dept Pediat, Denver, CO 80262 USA
[3] Northwestern Univ, Sch Med, Dept Pediat, Chicago, IL 60611 USA
[4] Univ Puerto Rico, Sch Med, Dept Pediat, San Juan, PR 00936 USA
关键词
bleeding; coagulation; dysprothrombinemia; hypoprothrombinemia; prothrombin; thrombin;
D O I
10.1046/j.1538-7836.2003.00420.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Five unrelated families with Puerto Rican ancestry were identified as having at least one member with bleeding due to a prothrombin deficiency. Genetic prothrombin deficiencies are extremely rare, but at the University of Puerto Rico Hemophilia Center, prothrombin deficiency is the third most common congenital coagulation factor deficiency. Because Puerto Rico is relatively isolated, there was a reasonable expectation of a founder effect. Prothrombin genes from probands and their parents were directly sequenced from PCR amplified exons using forward and reverse primers. Four novel prothrombin mutations were identified. The first, a G-->A substitution at DNA position 10150 predicting an Arg457-->Gln (R457Q) replacement, is common to all five families. In two of the families, the proband children are homozygous for R457Q. In the other three families, the probands are compound heterozygotes for R457Q and one of the other three mutations, which include another point mutation (gamma16Q), a deletion and a splice junction mutation. The two point mutations have been designated Puerto Rico I and Puerto Rico II. The crystal structure of alpha-thrombin predicts that the R457Q mutation removes a salt bridge that links the A- and B-chains of thrombin. The primary effect of this defect appears to be destabilization of the circulating prothrombin, creating a moderate hypoprothrombinemia. However, prothrombin antigen/activity ratios indicate a dysprothrombinemia as well, most likely due to the inability of R457Q prothrombin to activate fully to thrombin.
引用
收藏
页码:2381 / 2388
页数:8
相关论文
共 35 条
  • [1] Akhavan S, 2000, THROMB HAEMOSTASIS, V84, P989
  • [2] Molecular and functional characterization of a natural homozygous Arg67His mutation in the prothrombin gene of a patient with a severe procoagulant defect contrasting with a mild hemorrhagic phenotype
    Akhavan, S
    De Cristofaro, R
    Peyvandi, F
    Lavoretano, S
    Landolfi, R
    Mannucci, PM
    [J]. BLOOD, 2002, 100 (04) : 1347 - 1353
  • [3] Gly319 → Arg substitution in the dysfunctional prothrombin Segovia
    Akhavan, S
    Rocha, E
    Zeinali, S
    Mannucci, PM
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 (03) : 667 - 669
  • [4] BAJAJ SP, 1973, J BIOL CHEM, V248, P7729
  • [5] THE REFINED 1.9 A CRYSTAL-STRUCTURE OF HUMAN ALPHA-THROMBIN - INTERACTION WITH D-PHE-PRO-ARG CHLOROMETHYLKETONE AND SIGNIFICANCE OF THE TYR-PRO-PRO-TRP INSERTION SEGMENT
    BODE, W
    MAYR, I
    BAUMANN, U
    HUBER, R
    STONE, SR
    HOFSTEENGE, J
    [J]. EMBO JOURNAL, 1989, 8 (11) : 3467 - 3475
  • [6] BODE W, 1992, PROTEIN SCI, V1, P426
  • [7] The biology of prothrombin
    Degen, SJF
    Sun, WY
    [J]. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 1998, 8 (02): : 203 - 224
  • [8] NUCLEOTIDE-SEQUENCE OF THE GENE FOR HUMAN-PROTHROMBIN
    DEGEN, SJF
    DAVIE, EW
    [J]. BIOCHEMISTRY, 1987, 26 (19) : 6165 - 6177
  • [9] DEGEN SJF, 1995, THROMB HAEMOSTASIS, V73, P203
  • [10] DEGEN SJF, 1995, MOL BIOL THROMBOSIS, P75